Annual FCF
-$17.78 M
+$8.29 M+31.80%
December 31, 2023
Summary
- As of February 7, 2025, EVAX annual free cash flow is -$17.78 million, with the most recent change of +$8.29 million (+31.80%) on December 31, 2023.
- During the last 3 years, EVAX annual FCF has fallen by -$4.95 million (-38.56%).
- EVAX annual FCF is now -789.79% below its all-time high of -$2.00 million, reached on December 31, 2018.
Performance
EVAX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
N/A
September 1, 2024
Summary
- EVAX quarterly free cash flow is not available.
Performance
EVAX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
N/A
September 1, 2024
Summary
- EVAX TTM free cash flow is not available.
Performance
EVAX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
EVAX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.8% | - | - |
| 3 y3 years | -38.6% | - | - |
| 5 y5 years | -789.8% | - | - |
EVAX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.8% | ||||
| 5 y | 5-year | -150.8% | +31.8% | ||||
| alltime | all time | -789.8% | +31.8% |
Evaxion Biotech A/S Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$17.78 M(-31.8%) | - | - |
| Dec 2022 | -$26.07 M(+11.9%) | - | - |
| Jun 2022 | - | -$5.27 M(-37.0%) | -$24.56 M(-10.0%) |
| Mar 2022 | - | -$8.37 M(+95.0%) | -$27.28 M(+17.1%) |
| Dec 2021 | -$23.29 M | -$4.29 M(-35.2%) | -$23.29 M(-1.7%) |
| Sep 2021 | - | -$6.63 M(-17.1%) | -$23.70 M(+19.5%) |
| Jun 2021 | - | -$8.00 M(+82.7%) | -$19.84 M(+39.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$4.38 M(-6.9%) | -$14.19 M(+10.6%) |
| Dec 2020 | -$12.83 M(+81.0%) | -$4.70 M(+69.9%) | -$12.83 M(+57.8%) |
| Sep 2020 | - | -$2.77 M(+17.8%) | -$8.13 M(+51.6%) |
| Jun 2020 | - | -$2.35 M(-22.1%) | -$5.36 M(+77.9%) |
| Mar 2020 | - | -$3.01 M | -$3.01 M |
| Dec 2019 | -$7.09 M(+254.7%) | - | - |
| Dec 2018 | -$2.00 M | - | - |
FAQ
- What is Evaxion Biotech A/S annual free cash flow?
- What is the all time high annual FCF for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S annual FCF year-on-year change?
- What is the all time high quarterly FCF for Evaxion Biotech A/S?
- What is the all time high TTM FCF for Evaxion Biotech A/S?
What is Evaxion Biotech A/S annual free cash flow?
The current annual FCF of EVAX is -$17.78 M
What is the all time high annual FCF for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high annual free cash flow is -$2.00 M
What is Evaxion Biotech A/S annual FCF year-on-year change?
Over the past year, EVAX annual free cash flow has changed by +$8.29 M (+31.80%)
What is the all time high quarterly FCF for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high quarterly free cash flow is -$2.35 M
What is the all time high TTM FCF for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high TTM free cash flow is -$3.01 M